The epidemiology of psychiatric disorders among women with breast cancer in South Korea: Analysis of national registry data

Psycho-Oncology

Volumn 23, Issue 1, 2014, Pages 35-39

  Kang, Jee In ^a   Sung, Na Young ^b   Park, Sang Jin ^c   Lee, Chong Gul ^d   Lee, Byung Ook ^c  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University   (South Korea)

^c National Health Insurance Corporation   (South Korea)

^d Health Insurance Policy Research Institute   (South Korea)

Author keywords

breast cancer; incidence; national registry data; oncology; psychiatric disorders

Indexed keywords

ADJUSTMENT DISORDER; ADULT; AGED; ANXIETY DISORDER; ARTICLE; BREAST CANCER; CANCER REGISTRY; DEPRESSION; EPIDEMIOLOGICAL DATA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MENTAL DISEASE; MIDDLE AGED; PREVALENCE; SLEEP DISORDER; SOMATOFORM DISORDER; SOUTH KOREA; VERY ELDERLY; YOUNG ADULT;

BREAST CANCER; INCIDENCE; NATIONAL REGISTRY DATA; ONCOLOGY; PSYCHIATRIC DISORDERS;

ADJUSTMENT DISORDERS; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANXIETY DISORDERS; BREAST NEOPLASMS; COMORBIDITY; DEPRESSIVE DISORDER; FEMALE; HUMANS; INCIDENCE; MENTAL DISORDERS; MIDDLE AGED; REGISTRIES; REPUBLIC OF KOREA; SLEEP DISORDERS; YOUNG ADULT;

EID: 84891633004     PISSN: 10579249     EISSN: 10991611     Source Type: Journal    
DOI: 10.1002/pon.3369     Document Type: Article

References (37)

1. Pinder KL, Ramirez AJ, Black ME, et al., Psychiatric disorder in patients with advanced breast cancer: prevalence and associated factors. Eur J Cancer 1993; 29A: 524-527.
2. Fann JR, Thomas-Rich AM, Katon WJ, et al., Major depression after breast cancer: a review of epidemiology and treatment. Gen Hosp Psychiatry 2008; 30: 112-126.
3. Mehnert A, Koch U,. Prevalence of acute and post-traumatic stress disorder and comorbid mental disorders in breast cancer patients during primary cancer care: a prospective study. Psycho-Oncology 2007; 16: 181-188.
4. Watson M, Haviland JS, Greer S, et al., Influence of psychological response on survival in breast cancer: a population-based cohort study. Lancet 1999; 354: 1331-1336.
5. Hjerl K, Andersen EW, Keiding N, et al,. Depression as a prognostic factor for breast cancer mortality. Psychosomatics 2003; 44: 24-30.
6. Giese-Davis J, Collie K, Rancourt KM, et al., Decrease in depression symptoms is associated with longer survival in patients with metastatic breast cancer: a secondary analysis. J Clin Oncol 2011; 29: 413-420.
7. Massie MJ,. Prevalence of depression in patients with cancer. J Natl Cancer Inst Monogr 2004; 32: 57-71.
8. Kissane DW, Grabsch B, Love A, et al., Psychiatric disorder in women with early stage and advanced breast cancer: a comparative analysis. Aust N Z J Psychiatry 2004; 38: 320-326.
9. Reuter K, Raugust S, Marschner N, Harter M,. Differences in prevalence rates of psychological distress and mental disorders in inpatients and outpatients with breast and gynaecological cancer. Eur J Cancer Care (Engl) 2007; 16: 222-230.
10. Ozalp E, Soygur H, Cankurtaran E, et al., Psychiatric morbidity and its screening in Turkish women with breast cancer: a comparison between the HADS and SCID tests. Psycho-Oncology 2008; 17: 668-675.
11. Palmer SC, Taggi A, Demichele A, Coyne JC,. Is screening effective in detecting untreated psychiatric disorders among newly diagnosed breast cancer patients? Cancer 2012; 118: 2735-2743.
12. Spiegel D, Giese-Davis J,. Depression and cancer: mechanisms and disease progression. Biol Psychiatry 2003; 54: 269-282.
13. Burgess C, Cornelius V, Love S, et al., Depression and anxiety in women with early breast cancer: five year observational cohort study. BMJ 2005; 330: 702.
14. Qiu J, Yang M, Chen W, et al., Prevalence and correlates of major depressive disorder in breast cancer survivors in Shanghai, China. Psycho-Oncology 2012; 21: 1331-1337.
15. Derogatis LR, Morrow GR, Fetting J, et al., The prevalence of psychiatric disorders among cancer patients. JAMA 1983; 249: 751-757.
16. Gandubert C, Carriere I, Escot C, et al., Onset and relapse of psychiatric disorders following early breast cancer: a case-control study. Psycho-Oncology 2009; 18: 1029-1037.
17. Christensen S, Zachariae R, Jensen AB, et al., Prevalence and risk of depressive symptoms 3-4 months post-surgery in a nationwide cohort study of Danish women treated for early stage breast-cancer. Breast Cancer Res Treat 2009; 113: 339-355.
18. Kissane DW, Clarke DM, Ikin J, et al., Psychological morbidity and quality of life in Australian women with early-stage breast cancer: a cross-sectional survey. Med J Aust 1998; 169: 192-196.
19. Ng CG, Boks MP, Zainal NZ, de Wit NJ,. The prevalence and pharmacotherapy of depression in cancer patients. J Affect Disord 2011; 131: 1-7.
20. Distress management. Clinical practice guidelines. J Natl Compr Canc Netw 2003; 1: 344-374.
21. Holland JC, Bultz BD,. The NCCN guideline for distress management: a case for making distress the sixth vital sign. J. Natl. Compr. Canc. Netw. 2007; 5: 3-7.
22. Mitchell AJ, Vahabzadeh A, Magruder K,. Screening for distress and depression in cancer settings: 10 lessons from 40 years of primary-care research. Psycho-Oncology 2011; 20: 572-584.
23. Miovic M, Block S,. Psychiatric disorders in advanced cancer. Cancer 2007; 110: 1665-1676.
24. Bultz BD, Carlson LE,. Emotional distress: the sixth vital sign in cancer care. J. Clin. Oncol. 2005; 23: 6440-6441.
25. National Health Insurance Statistical Yearbook, Seoul, South Korea. 2008.
26. Falagas ME, Zarkadoulia EA, Ioannidou EN, et al., The effect of psychosocial factors on breast cancer outcome: a systematic review. Breast Cancer Res 2007; 9: R44.
27. Spiegel D,. Cancer and depression. Br J Psychiatry Suppl 1996; 109-116.
28. Hilakivi-Clarke L, Rowland J, Clarke R, Lippman ME,. Psychosocial factors in the development and progression of breast cancer. Breast Cancer Res. Treat. 1994; 29: 141-160.
29. Ganz PA, Rowland JH, Desmond K, et al,. Life after breast cancer: understanding women's health-related quality of life and sexual functioning. J. Clin. Oncol. 1998; 16: 501-514.
30. Ganz PA,. Psychological and social aspects of breast cancer. Oncology (Williston Park) 2008; 22: 642-646, 650; discussion 650, 653.
31. Begovic-Juhant A, Chmielewski A, Iwuagwu S, Chapman LA,. Impact of body image on depression and quality of life among women with breast cancer. J Psychosoc Oncol 2012; 30: 446-460.
32. Musselman DL, Miller AH, Porter MR, et al., Higher than normal plasma interleukin-6 concentrations in cancer patients with depression: preliminary findings. Am J Psychiatry 2001; 158: 1252-1257.
33. Capuron L, Ravaud A, Gualde N, et al., Association between immune activation and early depressive symptoms in cancer patients treated with interleukin-2-based therapy. Psychoneuroendocrinology 2001; 26: 797-808.
34. Reiche EM, Nunes SO, Morimoto HK,. Stress, depression, the immune system, and cancer. Lancet Oncol 2004; 5: 617-625.
35. Miller AH, Ancoli-Israel S, Bower JE, et al., Neuroendocrine-immune mechanisms of behavioral comorbidities in patients with cancer. J. Clin. Oncol. 2008; 26: 971-982.
36. Kimm HJ, Yun JE, Lee SH, et al,. Validity of the diagnosis of acute myocardial infarction in Korean national medical health insurance claims data. Korean Circulation Journal 2012; 42: 10-15.
37. Park JK, Kim KS, Kim CB,. The accuracy of ICD codes for cerebrovascular diseases in medical insurance claims. Korean J Prev Med 2000; 33: 76-82.